Endothelin receptor antagonist improves donor lung function in an ex vivo perfusion system

zu Verbundenen Objekten

Standort
Deutsche Nationalbibliothek Frankfurt am Main
ISSN
1423-0127
Umfang
Online-Ressource
Sprache
Englisch
Anmerkungen
online resource.

Erschienen in
Endothelin receptor antagonist improves donor lung function in an ex vivo perfusion system ; volume:27 ; number:1 ; day:2 ; month:10 ; year:2020 ; pages:1-9 ; date:12.2020
Journal of biomedical science ; 27, Heft 1 (2.10.2020), 1-9, 12.2020

Urheber
Walweel, K.
Skeggs, K.
Boon, A. C.
See Hoe, L. E.
Bouquet, M.
Obonyo, N. G.
Pedersen, S. E.
Diab, S. D.
Passmore, M. R.
Hyslop, K.
Wood, E. S.
Reid, J.
Colombo, S. M.
Bartnikowski, N. J.
Wells, M. A.
Black, D.
Pimenta, L. P.
Stevenson, A. K.
Bisht, K.
Marshall, L.
Prabhu, D. A.
James, L.
Platts, D. G.
Macdonald, P. S.
McGiffin, D. C.
Suen, J. Y.
Fraser, J. F.
Beteiligte Personen und Organisationen
SpringerLink (Online service)

DOI
10.1186/s12929-020-00690-7
URN
urn:nbn:de:101:1-2020112117573826723306
Rechteinformation
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Letzte Aktualisierung
15.08.2025, 07:26 MESZ

Datenpartner

Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Original beim Datenpartner anzeigen

Beteiligte

  • Walweel, K.
  • Skeggs, K.
  • Boon, A. C.
  • See Hoe, L. E.
  • Bouquet, M.
  • Obonyo, N. G.
  • Pedersen, S. E.
  • Diab, S. D.
  • Passmore, M. R.
  • Hyslop, K.
  • Wood, E. S.
  • Reid, J.
  • Colombo, S. M.
  • Bartnikowski, N. J.
  • Wells, M. A.
  • Black, D.
  • Pimenta, L. P.
  • Stevenson, A. K.
  • Bisht, K.
  • Marshall, L.
  • Prabhu, D. A.
  • James, L.
  • Platts, D. G.
  • Macdonald, P. S.
  • McGiffin, D. C.
  • Suen, J. Y.
  • Fraser, J. F.
  • SpringerLink (Online service)

Ähnliche Objekte (12)

Structural basis of antagonist selectivity in endothelin receptors

Structural basis of antagonist selectivity in endothelin receptors

Effekt von Endothelin-1 und Endothelin-A-Rezeptor-Antagonist auf die Mikrozirkulation bei TNBS-Colitis

Hochschulschrift

Effekt von Endothelin-1 und Endothelin-A-Rezeptor-Antagonist auf die Mikrozirkulation bei TNBS-Colitis

Endothelin receptor antagonist and airway dysfunction in pulmonary arterial hypertension

Endothelin receptor antagonist and airway dysfunction in pulmonary arterial hypertension

Endothelin receptor antagonist and airway dysfunction in pulmonary arterial hypertension

Endothelin receptor antagonist and airway dysfunction in pulmonary arterial hypertension

Treatment of nonarteritic anterior ischemic optic neuropathy with an endothelin antagonist: ENDOTHELION (ENDOTHELin antagonist receptor in Ischemic Optic Neuropathy)—a multicentre randomised controlled trial protocol

Treatment of nonarteritic anterior ischemic optic neuropathy with an endothelin antagonist: ENDOTHELION (ENDOTHELin antagonist receptor in Ischemic Optic Neuropathy)—a multicentre randomised controlled trial protocol

Macitentan: entry-into-humans study with a new endothelin receptor antagonist

Macitentan: entry-into-humans study with a new endothelin receptor antagonist

Expanding Donor Heart Utilization Through Machine Perfusion Technologies

Expanding Donor Heart Utilization Through Machine Perfusion Technologies

Cetirizine a histamine H1 receptor antagonist improves viral myocarditis

Cetirizine a histamine H1 receptor antagonist improves viral myocarditis

Aprocitentan, A Dual Endothelin Receptor Antagonist Under Development for the Treatment of Resistant Hypertension

Aprocitentan, A Dual Endothelin Receptor Antagonist Under Development for the Treatment of Resistant Hypertension

Distribution of Endothelin Receptor Subtypes in the Rat Kidney Renal and Haemodynamic Effects of the Mixed (A/B) Endothelin Receptor Antagonist Bosentan

Distribution of Endothelin Receptor Subtypes in the Rat Kidney Renal and Haemodynamic Effects of the Mixed (A/B) Endothelin Receptor Antagonist Bosentan

Potent anti-inflammatory and antinociceptive activity of the endothelin receptor antagonist bosentan in monoarthritic mice

Potent anti-inflammatory and antinociceptive activity of the endothelin receptor antagonist bosentan in monoarthritic mice

Ambrisentan, an endothelin receptor type A-selective antagonist, inhibits cancer cell migration, invasion, and metastasis

Ambrisentan, an endothelin receptor type A-selective antagonist, inhibits cancer cell migration, invasion, and metastasis

Verbundene Objekte